Background: The new, employee health plan (EHP) focused, population health initiative was established at Atrium Health Wake Forest Baptist in October 2020. The initiative's goals are to reduce health care costs and optimize patient care by providing patient-specific recommendations to help manage chronic disease states in the ambulatory care setting. This project's purpose is to quantify and categorize pharmacist recommendations implemented and not implemented.
Objective: Describe the implementation of pharmacist recommendations in a new, population health program.
Methods: Eligible patients: >18 years of age, diagnosed with type 2 diabetes, baseline HbA1c > 8%, and enrolled in the EHP. Patients were identified retrospectively through an electronic health record report. The primary endpoint assessed the proportion of pharmacist recommendations implemented. Interventions implemented and not implemented were categorized and reviewed for timely optimization of patient care and quality improvement.
Results: Overall, 55.7% of pharmacist recommendations were implemented. The most common reason recommendations were not implemented was that they were not addressed by the provider. The most common pharmacist recommendation was a drug therapy addition. Recommendations were implemented in a median time of 44 days.
Conclusion: Over half of pharmacist recommendations were implemented. Provider communication and awareness was identified as a barrier for this new initiative. Increasing provider education and advertisement of pharmacist services should be considered to increase future implementation rates. The project identified a need for optimization of timely patient care by prioritizing patient charts prior to their next applicable provider visit.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.japh.2023.01.011 | DOI Listing |
J Oncol Pharm Pract
March 2025
Department of Pharmacy Management, Faculty of Pharmacy, Gazi University, 06330, Ankara, Türkiye.
BackgroundOpioid therapy is a critical component in managing pain in palliative care, where pharmacists' specialised expertise is crucial in ensuring quality care for patients. This systematic review aims to document available evidence on pharmacist interventions and their impact on optimising opioid therapy for pain management in palliative care patients.MethodsWe searched Medline (OVID), Embase (OVID), APA PsycINFO and Cochrane Central Register of Controlled Trials (CENTRAL) for relevant articles published from the beginning to 31 December, 2022.
View Article and Find Full Text PDFJ Opioid Manag
March 2025
Outpatient Chronic Pain Clinical Pharmacist Practitioner, VA Salt Lake City Health Care System, Salt Lake City, Utah.
Objective: Create a standardized protocol document on how to convert patients from full opioid agonist to buprenorphine. Providing patients with the best possible chance of a seamless conversion resulting in decreased risk of failure of therapy with buprenorphine.
Methods: A 10-question survey was distributed to better understand the different aspects the providers consider when converting a patient from full opioid agonist to buprenorphine.
Medicine (Baltimore)
March 2025
Emergency Department, Toxicology Division, MacKay Memorial Hospital, Taipei, Taiwan.
Polypharmacy, the use of multiple medications, is a prevalent issue globally that contributes to increased healthcare costs and places additional burdens on patients' organs. This study aims to deprescribe and prevent polypharmacy in the emergency department. We conducted a retrospective review of randomly selected medical records from the Internal Medicine Department of Taipei MacKay Emergency Department, spanning from August 1, 2023, to October 31, 2023.
View Article and Find Full Text PDFContemp Clin Trials Commun
April 2025
Department of Pharmacy, Nimes University Hospital, Univ Montpellier, Nimes, France.
Background: causes infections especially in patients with immunodeficiency or specific comorbidities. Most could be avoided through pneumococcal vaccination (PV), but PV coverage is only 20 % in France. Many studies assess methods on vaccination coverage improvement, but none evaluates pharmacist-physician collaboration in hospital on PV coverage of inpatients at-risk of invasive pneumococcal disease (IPD).
View Article and Find Full Text PDFRes Social Adm Pharm
March 2025
Children's Wisconsin, Milwaukee, WI, USA.
Background: The increasing prevalence of mental health conditions in pediatric patients highlights the need for improved care. With long wait times and shortages in child and adolescent psychiatrists, primary care providers (PCPs) and pharmacists can help fill this gap.
Objective: The objective of this study was to evaluate the outcomes of a primary care mental and behavioral health pharmacist consult service in a pediatric health system.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!